New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2014
10:00 EDTSLM, NAVI, MON, KORS, MEI, MRVL, KATE, HAR, GTE, THRM, GNTX, GST, GCAP, CBMXOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: CombiMatrix (CBMX) initiated with a Buy at Ladenburg... GAIN Capital (GCAP) initiated with an Outperform at Keefe Bruyette... Gastar Exploration (GST) initiated with a Buy at Wunderlich... Gentex (GNTX) initiated with an Outperform at FBR Capital... Gentherm (THRM) initiated with a Market Perform at FBR Capital... Gran Tierra (GTE) initiated with a Neutral at Goldman... Harman (HAR) initiated with a Market Perform at FBR Capital... Kate Spade (KATE) initiated with a Buy at Nomura... Marvell (MRVL) initiated with an Equal Weight at Morgan Stanley... Methode Electronics (MEI) initiated with an Outperform at FBR Capital... Michael Kors (KORS) initiated with a Buy at Nomura... Monsanto (MON) initiated with an Outperform at BMO Capital... Navient (NAVI) initiated with an Equalweight at Barclays... Sallie Mae (SLM) initiated with a Neutral at Janney Capital.
News For CBMX;GCAP;GST;GNTX;THRM;GTE;HAR;KATE;MRVL;MEI;KORS;MON;NAVI;SLM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 10, 2014
12:05 EDTMONUSDA raises U.S. corn production estimate to 14.475B
Subscribe for More Information
10:09 EDTMRVLMarvell management to meet with JPMorgan
Subscribe for More Information
October 9, 2014
16:08 EDTGCAPGAIN Capital reports September retail volume $239B, institutional volume $441.5B
Subscribe for More Information
11:00 EDTGSTOptions with increasing implied volatility
Options with increasing implied volatility: ARWR PBR EXXI PWE GST GLNG WTW AFSI ETE VALE
October 8, 2014
10:00 EDTMRVLOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:29 EDTMONMonsanto targets at least double ongoing EPS by FY19
Subscribe for More Information
08:08 EDTMONMonsanto sees Q1 earnings roughly half last year, FY15 growth concentrated in Q3
Monsanto said, "As its business has expanded globally over the past several years, the company has seen its earnings flow evolve between quarters. This trend continues in FY15 as the company anticipates an overall shift in its full-year earnings pattern, as several structural factors result in a full-year earnings flow with a smaller first quarter and a concentration of growth in the third quarter. With macro conditions resulting in lower planted acres for key regions in both corn and cotton in the quarter, combined with a timing shift as the company moves more of its Agricultural Productivity business to branded-product sales, Monsanto expects its first quarter will be roughly half of the total earnings from the first quarter of 2014. Beyond the first quarter, the biggest first half timing effect relates to the evolution in its Channel seed brand business model that is expected to shift business timing from the first and second quarters to the third quarter. The company expects second quarter earnings to be relatively flat year-over-year with a significant uptick in third quarter earnings reflecting the timing shifts and business growth in its largest markets. The earnings flow is punctuated by a fourth quarter that is expected to be break-even to positive year-over-year on an absolute basis."
08:06 EDTMONMonsanto reports Q4 Seeds and Genomics sales $1.376B
Reports Q4 Agricultural Productivity sales $1.254B. Hugh Grant, chairman and CEO for Monsanto, said, “In an industry that’s particularly near-term focused right now, there are few companies as well positioned to deliver strong growth today while significantly increasing investments to enable the continued delivery of a broad range of innovative solutions for tomorrow.”
08:04 EDTMONMonsanto sees FY15 EPS $5.75-$6.00, consensus $6.03
Subscribe for More Information
08:02 EDTMONMonsanto reports Q4 ongoing EPS (27c), consensus (24c)
Subscribe for More Information
07:42 EDTMRVLMarvell initiated with a Buy at Ladenburg
Subscribe for More Information
October 7, 2014
15:16 EDTMONNotable companies reporting before tomorrow's open
Subscribe for More Information
15:08 EDTMONMonsanto technical notes ahead of earnings
In the prior three months the shares have underperformed, dropping nearly 14% in price. The trend has been bearish with a few volatile upside attempts which did not hold. Ahead of results, the stock has broken below an important support at the $110 area. This level has held as support since early March of this year. A continued breakdown below it on negative news would snap the 5-year uptrend line which has support at $110. Support levels to watch as potential downside objectives are at $105.45, $99.98, and $96.11. A break of the long-term uptrend line would be long-term bearish for share price. If the news surprises on the upside, resistance levels to watch as potential upside objectives are at $115.39, $118.99, and $121.85.
14:33 EDTMONMonsanto October weekly 108 straddle priced for 3% move into Q4
Subscribe for More Information
10:43 EDTGSTOptions with decreasing implied volatility
Subscribe for More Information
09:42 EDTKORSMichael Kors mentioned positively at OTR Global
Subscribe for More Information
08:17 EDTCBMXCombiMatrix expects Q3 prenatal tests volume up 71%
CombiMatrix announced that it expects to report record volumes of prenatal testing in the Q3 and nine months ended September 30, 2014. Preliminary growth rates of 71% and 64% are estimated for billable prenatal tests in the Q3 and year-to-date periods, respectively, compared to the comparable periods in 2013. The Company believes the growth rate in prenatal testing, which includes both prenatal and miscarriage testing, is the result of the Company's strategic shift to focus on its prenatal molecular diagnostics testing markets, where the Company believes that chromosomal microarray analysis is becoming the standard of care. Total microarray testing volumes for the Q3 is expected to increase 24% to 1,420 billable tests performed, compared to 1,145 tests performed in the third quarter of 2013. The Company also expects to report record cash receipts for the Q3 and nine months ended September 30, which are expected to be over $2.0M and $5.4M respectively, compared to $1.5M and $4.4M, respectively, in the comparable 2013 periods. Record cash reimbursement can be attributable to increased microarray revenues coupled with increased management focus on reimbursement and collections during the past year. The Company expects to announce complete results for the quarter and conduct a conference call following the completion of its independent auditors' review.
October 6, 2014
12:42 EDTMONMonsanto volatility increases into Q4 and revenue outlook
Monsanto October weekly call option implied volatility is at 41, October is at 26, November is at 19, January is at 18; compared to its 26-week average of 19 according to Track Data, suggesting large near term price movement into its expected release of Q4 results on October 8.
09:39 EDTKATEKate Spade mentioned positively at OTR Global
Subscribe for More Information
06:49 EDTKORSMichael Kors global growth remains intact, says Piper Jaffray
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use